Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04419402
Title Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer (ENZA-p)
Acronym ENZA-p
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Chris O'Brien Lifehouse Camperdown New South Wales 2050 Australia Details
St Vincents Hospital Darlinghurst New South Wales 2010 Australia Details
St George Hospital Kogarah New South Wales 2217 Australia Details
Liverpool Hospital Liverpool New South Wales 2170 Australia Details
Macquarie University Hospital Macquarie Park New South Wales 2109 Australia Details
Calvary Mater Newcastle Newcastle New South Wales 2298 Australia Details
Northern Cancer Institute Sydney New South Wales 2065 Australia Details
Royal Brisbane and Women's Hospital Brisbane Queensland 4029 Australia Details
Royal Adelaide Hospital Adelaide South Australia 5000 Australia Details
Monash Health Clayton Victoria 3168 Australia Details
Austin Health Heidelberg Victoria 3084 Australia Details
Peter MacCallum Cancer Centre Melbourne Victoria 3002 Australia Details
The Alfred Hospital Melbourne Victoria 3004 Australia Details
Sir Charles Gairdner Hospital Nedlands Western Australia 6009 Australia Details
Fiona Stanley Hospital Perth Western Australia 6150 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field